We look forward to filing for market approval in China as soon as possible to bring HRS9531 to patients struggling with obesity and overweight. We commend our colleagues at Hengrui for these impressive Phase 3 clinical results, building on the strong momentum behind HRS9531 (KAI-9531)
Any anti-inflammatory benefit tirzepatide provides supplements, not replaces, established autoimmune therapy
It is a once-weekly injectable therapy designed to improve glycemic control in adults whose blood sugar is not adequately controlled with diet, exercise, or other antidiabetic medications
There is no flat per-compound pricing
Gut microbiome changes from probiotics and fiber take several weeks to develop
Always check if the products are registered with the FDA by using the FDA Verification Portal feature accessible at All Local Government Units (LGUs) and Law Enforcement Agencies (LEAs) are requested to ensure that these products are not sold or made available in their localities or areas of jurisdiction